Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CRAFT Cali 29:01
- Development stage
- Phase 3
- Lead developer
- DEMECAN
- Administration
- Inhalation
01
Overview
CRAFT Cali 29:01 is an unirradiated, Indica-dominant hybrid medical cannabis flower product distributed by DEMECAN. Cultivated in Canada by Mill Creek Growth and imported into Germany, the strain is a genetic cross of Hawaiian Rain (London Pound Mints x Jealousy) and Permanent Marker (Biscotti S1 x Sherb Bx1 x Jealousy F2). It features a cannabinoid profile of approximately 29% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD). CRAFT Cali 29:01 is prescribed for the management of various conditions, including chronic pain, depression, sleep disorders, headaches, and stress, acting primarily as a partial agonist at cannabinoid receptors CB1 and CB2.
- Brand names
- CRAFT Cali 29:01Demecan Craft Cali 29:01
- Other names
- Cali 29:01Hawaiian Rain X Permanent Marker
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on CRAFT Cali 29:01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CRAFT Cali 29:01.